Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Commentaries on 'procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections' with a response from the review authors.

Sabhaney V, Enarson P, Irwin AD, Carrol ED.

Evid Based Child Health. 2013 Jul;8(4):1372-4. doi: 10.1002/ebch.1928.

PMID:
23877945
2.

Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.

Schuetz P, Müller B, Christ-Crain M, Stolz D, Tamm M, Bouadma L, Luyt CE, Wolff M, Chastre J, Tubach F, Kristoffersen KB, Burkhardt O, Welte T, Schroeder S, Nobre V, Wei L, Bhatnagar N, Bucher HC, Briel M.

Evid Based Child Health. 2013 Jul;8(4):1297-371. doi: 10.1002/ebch.1927. Review.

PMID:
23877944
3.

Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.

Schuetz P, Müller B, Christ-Crain M, Stolz D, Tamm M, Bouadma L, Luyt CE, Wolff M, Chastre J, Tubach F, Kristoffersen KB, Burkhardt O, Welte T, Schroeder S, Nobre V, Wei L, Bhatnagar N, Bucher HC, Briel M.

Cochrane Database Syst Rev. 2012 Sep 12;(9):CD007498. doi: 10.1002/14651858.CD007498.pub2. Review.

PMID:
22972110
4.

Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial.

Christ-Crain M, Jaccard-Stolz D, Bingisser R, Gencay MM, Huber PR, Tamm M, Müller B.

Lancet. 2004 Feb 21;363(9409):600-7.

PMID:
14987884
5.

[Is procalcitonin determination for control of antibiotic therapy in acute respiratory infections of value?].

Schütz P, Müller B, Briel M.

Praxis (Bern 1994). 2013 Mar 27;102(7):413-4. doi: 10.1024/1661-8157/a001241. Review. German. No abstract available.

PMID:
23531909
6.

Procalcitonin-guided antibiotic therapy in COPD exacerbations: closer but not quite there.

Martinez FJ, Curtis JL.

Chest. 2007 Jan;131(1):1-2. No abstract available.

PMID:
17218546
7.

Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.

Stannard D.

Crit Care Nurse. 2014 Apr;34(2):75-6. doi: 10.4037/ccn2014559. Review. No abstract available.

8.

Can procalcitonin levels guide antibiotic therapy in bacterial infections and reduce antibiotic overconsumption without having a negative effect on clinical outcomes?

Sandifer JP, Jones AE.

Ann Emerg Med. 2012 Sep;60(3):370-1. doi: 10.1016/j.annemergmed.2012.01.007. Review. No abstract available.

PMID:
22305332
9.

Procalcitonin-guided antibiotic use in acute respiratory tract infections.

Bollu M, Marte-Grau AC, Bobba RK.

Arch Intern Med. 2009 Apr 13;169(7):716. doi: 10.1001/archinternmed.2009.27. No abstract available.

PMID:
19365003
10.

Response by authors.

Schuetz P, Briel M, Bucher HC, Mueller B; Procalcitonin-stewardship study group..

Evid Based Child Health. 2013 Jul;8(4):1374-5. No abstract available.

PMID:
24040680
11.

[Procalcitonin as a biomarker in infections].

Christ-Crain M.

Praxis (Bern 1994). 2007 Jun 20;96(25-26):1017-21. Review. German. No abstract available.

PMID:
17639964
12.

Procalcitonin-guided antibiotic use in primary care: the ultimate proof still ahead.

Damoiseaux RA.

Arch Intern Med. 2009 Apr 13;169(7):717-8. doi: 10.1001/archinternmed.2009.31. No abstract available.

PMID:
19365004
13.

Procalcitonin-guided antibiotic use vs a standard approach for acute respiratory tract infections in primary care.

Briel M, Schuetz P, Mueller B, Young J, Schild U, Nusbaumer C, Périat P, Bucher HC, Christ-Crain M.

Arch Intern Med. 2008 Oct 13;168(18):2000-7; discussion 2007-8. doi: 10.1001/archinte.168.18.2000.

PMID:
18852401
14.

How efficient is procalcitonin-guided antibiotic use in acute respiratory tract infections in primary care?

Brusius AC, Zavascki AP, Fuchs SC.

Arch Intern Med. 2009 Jul 13;169(13):1244. doi: 10.1001/archinternmed.2009.182. No abstract available. Erratum in: Arch Intern Med. 2011 Sep 26;171(17):1540. Costa, Sandra [corrected Fuchs, Sandra C].

PMID:
19597077
15.

Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy.

Stolz D, Christ-Crain M, Bingisser R, Leuppi J, Miedinger D, Müller C, Huber P, Müller B, Tamm M.

Chest. 2007 Jan;131(1):9-19.

PMID:
17218551
16.

Management of patients with respiratory infections in primary care: procalcitonin, C-reactive protein or both?

Meili M, Müller B, Kulkarni P, Schütz P.

Expert Rev Respir Med. 2015 Oct;9(5):587-601. doi: 10.1586/17476348.2015.1081063. Review.

PMID:
26366806
17.
18.

Is serum procalcitonin a reliable diagnostic marker in children with acute respiratory tract infections? A retrospective analysis.

Schützle H, Forster J, Superti-Furga A, Berner R.

Eur J Pediatr. 2009 Sep;168(9):1117-24. doi: 10.1007/s00431-008-0899-3.

PMID:
19107517
19.

Clinical outcomes associated with procalcitonin algorithms to guide antibiotic therapy in respiratory tract infections.

Schuetz P, Briel M, Mueller B.

JAMA. 2013 Feb 20;309(7):717-8. doi: 10.1001/jama.2013.697.

PMID:
23423417
20.

Procalcitonin algorithms for antibiotic therapy decisions: a systematic review of randomized controlled trials and recommendations for clinical algorithms.

Schuetz P, Chiappa V, Briel M, Greenwald JL.

Arch Intern Med. 2011 Aug 8;171(15):1322-31. doi: 10.1001/archinternmed.2011.318. Review.

PMID:
21824946
Items per page

Supplemental Content

Support Center